D. Libster

发表

Primary ALK Positive Anaplastic Large Cell Lymphoma of the Pancreas

D. B. Yehuda, G. Amir, A. Polliack, 2003, Leukemia & lymphoma.

Large‐cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine–rituximab‐containing regimens: natural history‐ or therapy‐related complication?

G. Amir, A. Polliack, N. Da’as, 2002, European journal of haematology.

Allergic reaction to chlorambucil in chronic lymphocytic leukemia presenting with fever and lymphadenopathy

M. Levin, D. Libster, 2005, Leukemia & lymphoma.

Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy

A. Gural, N. Goldschmidt, D. Lavie, 2017, American journal of hematology.

Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis

A. Gural, N. Goldschmidt, D. Lavie, 2018, European journal of haematology.

Evidence for clinical and genetic heterogeneity in hereditary benign telangiectasia.

I. Lerer, D. Abeliovich, A. Zlotogorski, 2007, Journal of the American Academy of Dermatology.

Bleeding, Obstruction, and Perforation in a Series of Patients With Aggressive Gastric Lymphoma Treated With Primary Chemotherapy

D. B. Yehuda, O. Paltiel, N. Da’as, 2006, Annals of Surgical Oncology.

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.

J. Rowe, I. Avivi, R. Bar-Shalom, 2007, Blood.

Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy

A. Gural, O. Paltiel, N. Goldschmidt, 2016, Cancer Chemotherapy and Pharmacology.

Large B-cell Lymphoma Manifesting as an Invasive Cardiac Mass: Sustained Local Remission after Combination of Methotrexate and Rituximab

A. Polliack, Y. Cohen, D. Gillon, 2002, Leukemia & lymphoma.

Risk factors and outcomes of COVID‐19 in adult patients with hematological malignancies: A single‐center study showing lower than expected rates of hospitalization and mortality

N. Goldschmidt, D. Lavie, Eran Zimran, 2023, European journal of haematology.

A 10‐year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved

J. Rowe, I. Avivi, D. Gaitini, 2012, American journal of hematology.

For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved.

J. Rowe, I. Avivi, Z. Blumenfeld, 2009 .

Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia

A. Gural, N. Goldschmidt, D. Lavie, 2014, Leukemia & lymphoma.

Polymorphisms in Exons 2 and 7 of the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients,

A. Gural, N. Goldschmidt, D. Lavie, 2011 .